1. Academic Validation
  2. Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans

Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans

  • Eur J Clin Pharmacol. 1990;39(6):603-5. doi: 10.1007/BF00316106.
T Thomsen 1 U Bickel J P Fischer H Kewitz
Affiliations

Affiliation

  • 1 Institut für Klinische Pharmacologie, FU-Berlin, Klinikum Steglitz, FRG.
Abstract

The effect of galanthamine (GAL) and its 2 major metabolites on human cholinesterases has been explored. Epigalanthamine, a diastereomer of GAL, was 130-times less potent in vitro in its effect on acetylcholinesterase (AChE) in erythrocytes than the parent compound, and it did not differ significantly from the ketone galanthaminone. In vivo, the maximal 36-55% inhibition of AChE was approached 30 min after oral administration of 10 mg GAL. The duration of the catalytic inhibition corresponded to an elimination half-life of approximately 5-7 h. GAL was well tolerated in 8/8 healthy volunteers, and 3/4 Alzheimer patients tolerated the drug up to a daily dose of 40 mg.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》